[1] NEWMAN A C, MADDOCKS O. One-carbon metabolism in cancer[J]. Br J Cancer, 2017, 116(12):1499-1504. [2] 刘颖慧,黎金颜,何淑明,等. 不同分型分期子宫内膜癌叶酸受体α的表达及诊断性能评估[J]. 实用医学杂志, 2018, 34(4):592-595. [3] LU J, TRABERT B, LIAO L M, et al. Dietary intake of nutrients involved in folate-mediatedone-carbon metabolism and risk for endometrial cancer[J]. Int J Epidemiol, 2019, 48(2):474-488. [4] DU L, WANG Y, ZHANG H, et al. Folate intake and the risk of endometrial cancer: A meta-analysis[J]. Oncotarget, 2016, 7(51):85176. [5] LIU J J, HAZRA A, GIOVANNUCCI E, et al. One-carbon metabolism factors and endometrial cancer risk[J]. Br J Cancer, 2013, 108(1):183-187. [6] ZHANG L, GE C, ZHAO F, et al. NRBP2 Overexpression increases the chemosensitivity of hepatocellular carcinoma cells via akt signaling[J]. Cancer Res, 2016, 76(23):7059-7071. [7] KIMMICH T, BRUNING A, KAUFL S D, et al. Inhibin/activin-beta C and -beta E subunits in the Ishikawa human endometrial adenocarcinoma cell line[J]. Arch Gynecol Obstet, 2010, 282(2):185-191. [8] JUCKSTOCK J, KIMMICH T, MYLONAS I, et al. The inhibin-betaC subunit is down-regulated, while inhibin-betaE is up-regulated by interferon-beta1a in Ishikawa carcinoma cell line[J]. Arch Gynecol Obstet, 2013, 288(4):883-888. [9] QU J, LIU B, LI B, et al. TRIB3 suppresses proliferation and invasion and promotes apoptosis of endometrial cancer cells by regulating the AKT signaling pathway[J]. Onco Targets Ther, 2019(12):2235-2245. |